Clustering patterns of human papillomavirus genotypes in multiple infections

Virus Research

Volumn 142, Issue 1-2, 2009, Pages 154-159

  Spinillo, Arsenio ^a   Dal Bello, Barbara ^b   Alberizzi, Paola ^b   Cesari, Stefania ^b   Gardella, Barbara ^a   Roccio, Marianna ^a   Silini, Enrico Maria ^c  

^a UNIVERSITY OF PAVIA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c UNIVERSITY HOSPITAL OF PARMA   (Italy)

Author keywords

Cancer; Cervical intraepithelial neoplasia (CIN); Cervix; Coinfection; Human papillomavirus (HPV); Squamous intraepithelial lesion (SIL)

Indexed keywords

ADULT; AGED; ARTICLE; DISEASE SEVERITY; FEMALE; GENOTYPE; HUMAN; HUMAN TISSUE; INFECTION PREVENTION; INFECTION RISK; MAJOR CLINICAL STUDY; MIXED INFECTION; PREVALENCE; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

ADOLESCENT; ADULT; AGED; ALPHAPAPILLOMAVIRUS; FEMALE; GENOTYPE; HUMANS; ITALY; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; YOUNG ADULT;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 67349232293     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2009.02.004     Document Type: Article

References (43)

1. Abramson J.H. WINPEPI (PEPI-for-Windows): computer programs for epidemiologists. Epidemiol. Perspect. Innov. 1 1 (2004) 6
2. Agresti A., and Coull B.A. Order-restricted tests for stratified comparisons of binomial proportions. Biometrics 52 3 (1996) 1103-1111
3. Birner P., Bachtiary B., Dreier B., Schindl M., Joura E.A., Breitenecker G., and Oberhuber G. Signal-amplified colorimetric in situ hybridization for assessment of human papillomavirus infection in cervical lesions. Mod. Pathol. 14 7 (2001) 702-709
4. Capra G., Giovannelli L., Bellavia C., Migliore M.C., Caleca M.P., Perino A., and Ammatuna P. HPV genotype prevalence in cytologically abnormal cervical samples from women living in south Italy. Virus Res. 133 2 (2008) 195-200
5. Castle P.E., Gravitt P.E., Solomon D., Wheeler C.M., and Schiffman M. Comparison of linear array and line blot assay for detection of human papillomavirus and diagnosis of cervical precancer and cancer in the atypical squamous cell of undetermined significance and low-grade squamous intraepithelial lesion triage study. J. Clin. Microbiol. 46 1 (2008) 109-117
6. Castle P.E., Jeronimo J., Schiffman M., Herrero R., Rodriguez A.C., Bratti M.C., Hildesheim A., Wacholder S., Long L.R., Neve L., Pfeiffer R., and Burk R.D. Age-related changes of the cervix influence human papillomavirus type distribution. Cancer Res. 66 2 (2006) 1218-1224
7. Castle P.E., Solomon D., Schiffman M., and Wheeler C.M. Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities. J. Natl. Cancer Inst. 97 14 (2005) 1066-1071
8. Chaturvedi A.K., Dumestre J., Gaffga A.M., Mire K.M., Clark R.A., Braly P.S., Dunlap K., Beckel T.E., Hammons A.F., Kissinger P.J., and Hagensee M.E. Prevalence of human papillomavirus genotypes in women from three clinical settings. J. Med. Virol. 75 1 (2005) 105-113
9. Chaturvedi A.K., and Goedert J.J. Human papillomavirus genotypes among women with HIV: implications for research and prevention. AIDS 20 18 (2006) 2381-2383
10. Chaturvedi A.K., Myers L., Hammons A.F., Clark R.A., Dunlap K., Kissinger P.J., and Hagensee M.E. Prevalence and clustering patterns of human papillomavirus genotypes in multiple infections. Cancer Epidemiol. Biomarkers Prev. 14 10 (2005) 2439-2445
11. Cuschieri K.S., Cubie H.A., Whitley M.W., Seagar A.L., Arends M.J., Moore C., Gilkisson G., and McGoogan E. Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population. J. Clin. Pathol. 57 1 (2004) 68-72
12. Fife K.H., Cramer H.M., Schroeder J.M., and Brown D.R. Detection of multiple human papillomavirus types in the lower genital tract correlates with cervical dysplasia. J. Med. Virol. 64 4 (2001) 550-559
13. Franco E.L., and Cuzick J. Cervical cancer screening following prophylactic human papillomavirus vaccination. Vaccine 26 Suppl. 1 (2008) A16-A23
14. Gargiulo F., De Francesco M.A., Schreiber C., Ciravolo G., Salinaro F., Valloncini B., and Manca N. Prevalence and distribution of single and multiple HPV infections in cytologically abnormal cervical samples from Italian women. Virus Res. 125 2 (2007) 176-182
15. Herrero R., Hildesheim A., Bratti C., Sherman M.E., Hutchinson M., Morales J., Balmaceda I., Greenberg M.D., Alfaro M., Burk R.D., Wacholder S., Plummer M., and Schiffman M. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J. Natl. Cancer Inst. 92 6 (2000) 464-474
16. Hiller T., Poppelreuther S., Stubenrauch F., and Iftner T. Comparative analysis of 19 genital human papillomavirus types with regard to p53 degradation, immortalization, phylogeny, and epidemiologic risk classification. Cancer Epidemiol. Biomarkers Prev. 15 7 (2006) 1262-1267
17. Ho G.Y., Bierman R., Beardsley L., Chang C.J., and Burk R.D. Natural history of cervicovaginal papillomavirus infection in young women. N. Engl. J. Med. 338 7 (1998) 423-428
18. Hosmer D.W., and Lemeshow S. Applied Logistic Regression (1989), John Wileys & Sons, New York, USA
19. Kleter B., van Doorn L.J., Schrauwen L., Molijn A., Sastrowijoto S., ter Schegget J., Lindeman J., ter Harmsel B., Burger M., and Quint W. Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J. Clin. Microbiol. 37 8 (1999) 2508-2517
20. Klug S.J., Molijn A., Schopp B., Holz B., Iftner A., Quint W., Snijders P.J.F., Petry K.U., Kruger Kjaer S., Munk C., and Iftner T. Comparison of the performance of different HPV genotyping methods for detecting genital HPV types. J. Med. Virol. 80 7 (2008) 1264-1274
21. Liaw K.L., Hildesheim A., Burk R.D., Gravitt P., Wacholder S., Manos M.M., Scott D.R., Sherman M.E., Kurman R.J., Glass A.G., Anderson S.M., and Schiffman M. A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types. J. Infect. Dis. 183 1 (2001) 8-15
22. Luostarinen T., af Geijersstam V., Bjorge T., Eklund C., Hakama M., Hakulinen T., Jellum E., Koskela P., Paavonen J., Pukkala E., Schiller J.T., Thoresen S., Youngman L.D., Dillner J., and Lehtinen M. No excess risk of cervical carcinoma among women seropositive for both HPV16 and HPV6/11. Int. J. Cancer 80 6 (1999) 818-822
23. McLaughlin-Drubin M.E., and Meyers C. Evidence for the coexistence of two genital HPV types within the same host cell in vitro. Virology 321 2 (2004) 173-180
24. Mendez F., Munoz N., Posso H., Molano M., Moreno V., van den Brule A.J., Ronderos M., Meijer C., and Munoz A. Cervical coinfection with human papillomavirus (HPV) types and possible implications for the prevention of cervical cancer by HPV vaccines. J. Infect. Dis. 192 7 (2005) 1158-1165
25. Moberg M., Gustavsson I., and Gyllensten U. Type-specific associations of human papillomavirus load with risk of developing cervical carcinoma in situ. Int. J. Cancer 112 5 (2004) 854-859
26. Perrons C., Jelley R., Kleter B., Quint W., and Brink N. Detection of persistent high risk human papillomavirus infections with hybrid capture II and SPF10/LiPA. J. Clin. Virol. 32 4 (2005) 278-285
27. Plummer M., Schiffman M., Castle P.E., Maucort-Boulch D., and Wheeler C.M. A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion. J. Infect. Dis. 195 11 (2007) 1582-1589
28. Roden R., and Wu T.C. How will HPV vaccines affect cervical cancer?. Nat. Rev. Cancer 6 10 (2006) 753-763
29. Rousseau M.C., Abrahamowicz M., Villa L.L., Costa M.C., Rohan T.E., and Franco E.L. Predictors of cervical coinfection with multiple human papillomavirus types. Cancer Epidemiol. Biomarkers Prev. 12 10 (2003) 1029-1037
30. Rousseau M.C., Pereira J.S., Prado J.C., Villa L.L., Rohan T.E., and Franco E.L. Cervical coinfection with human papillomavirus (HPV) types as a predictor of acquisition and persistence of HPV infection. J. Infect. Dis. 184 12 (2001) 1508-1517
31. Rousseau M.C., Villa L.L., Costa M.C., Abrahamowicz M., Rohan T.E., and Franco E. Occurrence of cervical infection with multiple human papillomavirus types is associated with age and cytologic abnormalities. Sex Transm. Dis. 30 7 (2003) 581-587
32. Safaeian M., Herrero R., Hildesheim A., Quint W., Freer E., Van Doorn L.J., Porras C., Silva S., Gonzalez P., Bratti M.C., Rodriguez A.C., and Castle P. Comparison of the SPF10-LiPA system to the Hybrid Capture 2 Assay for detection of carcinogenic human papillomavirus genotypes among 5,683 young women in Guanacaste, Costa Rica. J. Clin. Microbiol. 45 5 (2007) 1447-1454
33. Stanley M. Immune responses to human papillomavirus. Vaccine 24 Suppl. 1 (2006) S16-S22
34. In: Tavassoli F.A., and Devilee P. (Eds). Pathology and Genetics Of Tumours of the Breast and Female Genital Organs. World Health Organization Classification of Tumours (2003), IARC Press, Lyon, France
35. Thomas K.K., Hughes J.P., Kuypers J.M., Kiviat N.B., Lee S.K., Adam D.E., and Koutsky L.A. Concurrent and sequential acquisition of different genital human papillomavirus types. J. Infect. Dis. 182 4 (2000) 1097-1102
36. Tornesello M.L., Duraturo M.L., Botti G., Greggi S., Piccoli R., De Palo G., Montella M., Buonaguro L., and Buonaguro F.M. Prevalence of alpha-papillomavirus genotypes in cervical squamous intraepithelial lesions and invasive cervical carcinoma in the Italian population. J. Med. Virol. 78 12 (2006) 1663-1672
37. Trottier H., Mahmud S., Costa M.C., Sobrinho J.P., Duarte-Franco E., Rohan T.E., Ferenczy A., Villa L.L., and Franco E.L. Human papillomavirus infections with multiple types and risk of cervical neoplasia. Cancer Epidemiol. Biomarkers Prev. 15 7 (2006) 1274-1280
38. Trottier H., Mahmud S., Prado J.C., Sobrinho J.S., Costa M.C., Rohan T.E., Villa L.L., and Franco E.L. Type-specific duration of human papillomavirus infection: implications for human papillomavirus screening and vaccination. J. Infect. Dis. 197 10 (2008) 1436-1447
39. van Doorn L.J., Quint W., Kleter B., Molijn A., Colau B., Martin M.T., Kravang I., Torrez-Martinez N., Peyton C.L., and Wheeler C.M. Genotyping of human papillomavirus in liquid cytology cervical specimens by the PGMY line blot assay and the SPF(10) line probe assay. J. Clin. Microbiol. 40 3 (2002) 979-983
40. van Hamont D., van Ham M.A., Bakkers J.M., Massuger L.F., and Melchers W.J. Evaluation of the SPF10-INNO LiPA human papillomavirus (HPV) genotyping test and the Roche linear array HPV genotyping test. J. Clin. Microbiol. 44 9 (2006) 3122-3129
41. Vermeulen C.F., Jordanova E.S., Szuhai K., Kolkman-Uljee S., Vrede M.A., Peters A.A., Schuuring E., and Fleuren G.J. Physical status of multiple human papillomavirus genotypes in flow-sorted cervical cancer cells. Cancer Genet. Cytogenet. 175 2 (2007) 132-137
42. Vinokurova S., Wentzensen N., Kraus I., Klaes R., Driesch C., Melsheimer P., Kisseljov F., Durst M., Schneider A., and von Knebel Doeberitz M. Type-dependent integration frequency of human papillomavirus genomes in cervical lesions. Cancer Res. 68 1 (2008) 307-313
43. Wheeler C.M., Hunt W.C., Schiffman M., and Castle P.E. Human papillomavirus genotypes and the cumulative 2-year risk of cervical precancer. J. Infect. Dis. 194 9 (2006) 1291-1299